Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,373 | 23,442 | 19,302 | 20,614 | 17,567 |
| Marketable Securities | 28,417 | 37,184 | 60,012 | 77,217 | 110,190 |
| TOTAL | $50,727 | $66,516 | $85,257 | $102,532 | $134,352 |
| Non-Current Assets | |||||
| PPE Net | 1,200 | 1,351 | 1,497 | 2,703 | 2,905 |
| Investments And Advances | 3,494 | 5,838 | 4,232 | 9,161 | 3,524 |
| Other Non-Current Assets | 3,625 | 9,018 | 4,334 | 6,504 | 6,994 |
| TOTAL | $8,319 | $16,207 | $10,063 | $18,368 | $13,423 |
| Total Assets | $59,046 | $82,723 | $95,320 | $120,900 | $147,775 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,217 | 4,348 | 3,043 | 1,739 | 435 |
| Accounts payable and accrued liabilities | 4,914 | 6,583 | 4,942 | 3,985 | 4,646 |
| Accrued Expenses | 14,422 | 16,791 | 10,863 | 13,018 | 13,419 |
| TOTAL | $24,553 | $27,722 | $18,848 | $18,742 | $18,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,532 | 5,764 | 6,997 | 8,232 | 9,469 |
| Other Non-Current Liabilities | 3,980 | 4,437 | 5,060 | 5,631 | 6,188 |
| TOTAL | $8,512 | $10,201 | $12,057 | $13,863 | $15,657 |
| Total Liabilities | $33,065 | $37,923 | $30,905 | $32,605 | $34,157 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 131,608 | 54,218 | 53,551 | 53,444 | 53,384 |
| Common Shares | 54 | 54 | 54 | 53 | 53 |
| Retained earnings | -722,817 | -699,969 | -677,825 | -651,876 | -621,122 |
| Other shareholders' equity | 28 | 43 | 36 | 118 | 275 |
| TOTAL | $25,981 | $44,800 | $64,415 | $88,295 | $113,618 |
| Total Liabilities And Equity | $59,046 | $82,723 | $95,320 | $120,900 | $147,775 |